Page last updated: 2024-11-08

alanine and Myotonic Disorders

alanine has been researched along with Myotonic Disorders in 2 studies

Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.

Myotonic Disorders: Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.

Research Excerpts

ExcerptRelevanceReference
"We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay."5.31L-alanine supplementation in late infantile glycogen storage disease type II. ( Bodamer, OA; Haas, D; Hermans, MM; Hoffmann, GF; Reuser, AJ, 2002)
"We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay."1.31L-alanine supplementation in late infantile glycogen storage disease type II. ( Bodamer, OA; Haas, D; Hermans, MM; Hoffmann, GF; Reuser, AJ, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodamer, OA1
Haas, D1
Hermans, MM1
Reuser, AJ1
Hoffmann, GF1
Bouhours, M1
Sternberg, D1
Davoine, CS1
Ferrer, X1
Willer, JC1
Fontaine, B1
Tabti, N1

Other Studies

2 other studies available for alanine and Myotonic Disorders

ArticleYear
L-alanine supplementation in late infantile glycogen storage disease type II.
    Pediatric neurology, 2002, Volume: 27, Issue:2

    Topics: Administration, Oral; Alanine; Cardiomyopathies; Dietary Supplements; Glycogen Storage Disease Type

2002
Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
    The Journal of physiology, 2004, Feb-01, Volume: 554, Issue:Pt 3

    Topics: Adult; Alanine; Amino Acid Substitution; Cell Line; Cold Temperature; Electrophysiology; Female; Hum

2004